Aspirin 'responsiveness', 'nonresponsiveness' or 'resistance': A putative role for von Willebrand factor?

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 8, 2008, Pages 823-824

  Kilanowska, Jolanta ^a   Favaloro, Emmanuel J ^a   Lippi, Giuseppe ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; VON WILLEBRAND FACTOR;

IN VITRO STUDY; IN VIVO STUDY; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE AGGREGATION; THROMBOSIS;

ASPIRIN; DRUG RESISTANCE; HUMANS; PLATELET AGGREGATION INHIBITORS; REPRODUCIBILITY OF RESULTS; VON WILLEBRAND FACTOR;

EID: 57149096916     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32830ef92b     Document Type: Letter

References (5)

1. McGlasson DL, Fritsma GA. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis 2008; 19:120-123.
2. Karon BS, Wockenfus A, Scott R, Hartman SJ, McConnell JP, Santrach PJ, Jaffe AS. Aspirin responsiveness in healthy volunteers measured with multiple assay platforms. Clin Chem 2008; 54:1060-1065.
3. Chakroun T, Gerotziafas G, Robert F, Lecrubier C, Samama MM, Hatmi M, Elalamy I. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004; 124:80-85.
4. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002; 9:407-415.
5. Franchini M, Lippi G. Von Willebrand factor and thrombosis. Ann Hematol 2006; 85:415-423.